Dose Finding Study of Gadavist in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to look at the safety (what are the side effects) and efficacy
(how well does it work) of Gadavist when used for taking images of the brain and spine. The
results of the MRI with Gadavist Injection will be compared to the results of MR images taken
without contrast and with the results of the MR images taken with OptiMARK.